Wednesday
18:45 - 20:15
Hortega Hall

The interplay of dysglycemia and dyslipidemia: Managing cardiovascular burden in individuals with high CV risk

Evening Session

Luis Masana (Spain)
Welcome and Introductions
Helen Colhoun (UK)
Urgency in treating dyslipidemia in individuals with diabetes and high CV risk
Luis Masana (Spain)
Individuals with diabetes and high CV risk who may benefit the most from PCSK9 inhibition in your clinical practice
Ann Marie Navar (USA)
Evaluating the benefit/risk and safety profile of PCSK9 inhibitors: implications in clinical practice
All panellists
Question and answer / panel discussion
Luis Masana (Spain)
Conclusion and key take-away messages
Symposium by: